MicroRNA in skeletal muscle development, growth, atrophy, and disease

Wiley Interdisciplinary Reviews: RNA

Volumn 5, Issue 4, 2014, Pages 509-525

  Kovanda, Anja ^a,b   Režen, Tadeja ^b   Rogelj, Boris ^a,b  

^a JO EF STEFAN INSTITUTE   (Slovenia)

^b Biomedical Research Institute BRIS   (Slovenia)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA; MYOMIR; UNCLASSIFIED DRUG;

AGING; AMYOTROPHIC LATERAL SCLEROSIS; ARTICLE; BECKER MUSCULAR DYSTROPHY; CHRONIC DISEASE; DISEASE ASSOCIATION; DISEASE COURSE; DUCHENNE MUSCULAR DYSTROPHY; ENVIRONMENTAL FACTOR; EXERCISE; GENE EXPRESSION; HOMEOSTASIS; HUMAN; IMMOBILITY; INFECTION; LONG TERM EXPOSURE; MICROGRAVITY; MUSCLE ATROPHY; MUSCLE CELL; MUSCLE DEVELOPMENT; MUSCLE GROWTH; MUSCLE REGENERATION; MUSCLE TISSUE; NEUROMUSCULAR DISEASE; NONHUMAN; PRIORITY JOURNAL; SKELETAL MUSCLE; TISSUE STRUCTURE; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOLOGY;

HUMANS; MICRORNAS; MUSCLE, SKELETAL; MUSCULAR ATROPHY;

EID: 84902546057     PISSN: 17577004     EISSN: 17577012     Source Type: Journal    
DOI: 10.1002/wrna.1227     Document Type: Article

References (147)

1. Bartel DP. MicroRNAs: target recognition and regulatory functions. Cell 2009, 136:215-233. doi: 10.1016/j.cell.2009.01.002.
2. Lee RC. An extensive class of small RNAs in Caenorhabditis elegans. Science 2001, 294:862-864. doi: 10.1126/science.1065329.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75:843-854.
4. Lewis BP, Shih I, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798. doi: 10.1016/S0092-8674(03)01018-3.
5. Lewis BP, Burge CB, Bartel DP. Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 2005, 120:15-20. doi: 10.1016/j.cell.2004.12.035.
6. Mourelatos Z. miRNPs: a novel class of ribonucleoproteins containing numerous microRNAs. Genes Dev 2002, 16:720-728. doi: 10.1101/gad.974702.
7. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, Horvitz HR, Ruvkun G. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature 2000, 403:901-906. doi: 10.1038/35002607.
8. Friedman RC, Farh KK-H, Burge CB, Bartel DP. Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 2008, 19:92-105. doi: 10.1101/gr.082701.108.
9. Kim VN, Han J, Siomi MC. Biogenesis of small RNAs in animals. Nat Rev Mol Cell Biol 2009, 10:126-139. doi: 10.1038/nrm2632.
10. Bratkovič T, Glavan G, Strukelj B, Zivin M, Rogelj B. Exploiting microRNAs for cell engineering and therapy. Biotechnol Adv 2012, 30:753-765. doi: 10.1016/j.biotechadv.2012.01.006.
11. Krol J, Loedige I, Filipowicz W. The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet 2010, 11:597-610. doi: 10.1038/nrg2843.
12. Rodriguez A, Griffiths-Jones S, Ashurst JL, Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res 2004, 14:1902-1910. doi: 10.1101/gr.2722704.
13. Yang J-S, Lai EC. Alternative miRNA biogenesis pathways and the interpretation of core miRNA pathway mutants. Mol Cell 2011, 43:892-903. doi: 10.1016/j.molcel.2011.07.024.
14. Lal A, Navarro F, Maher CA, Maliszewski LE, Yan N, O'Day E, Chowdhury D, Dykxhoorn DM, Tsai P, Hofmann O, et al. miR-24 Inhibits cell proliferation by targeting E2F2, MYC, and other cell-cycle genes via binding to "seedless" 3′UTR microRNA recognition elements. Mol Cell 2009, 35:610-625. doi: 10.1016/j.molcel.2009.08.020.
15. Shin C, Nam J-W, Farh KK-H, Chiang HR, Shkumatava A, Bartel DP. Expanding the microRNA targeting code: functional sites with centered pairing. Mol Cell 2010, 38:789-802. doi: 10.1016/j.molcel.2010.06.005.
16. Van Rooij E, Quiat D, Johnson BA, Sutherland LB, Qi X, Richardson JA, Kelm RJ Jr, Olson EN. A family of microRNAs encoded by myosin genes governs myosin expression and muscle performance. Dev Cell 2009, 17:662-673. doi: 10.1016/j.devcel.2009.10.013.
17. Callis TE, Chen J-F, Wang D-Z. MicroRNAs in skeletal and cardiac muscle development. DNA Cell Biol 2007, 26:219-225. doi: 10.1089/dna.2006.0556.
18. Chen J-F, Callis TE, Wang D-Z. MicroRNAs and muscle disorders. J Cell Sci 2008, 122:13-20. doi: 10.1242/jcs.041723.
19. Drummond MJ. MicroRNAs and exercise-induced skeletal muscle adaptations. J Physiol 2010, 588:3849-3850. doi: 10.1113/jphysiol.2010.198218.
20. Ge Y, Chen J. MicroRNAs in skeletal myogenesis. Cell Cycle 2011, 10:441-448. doi: 10.4161/cc.10.3.14710.
21. Wang XH. MicroRNA in myogenesis and muscle atrophy. Curr Opin Clin Nutr Metab Care 2013, 16:258-266. doi: 10.1097/MCO.0b013e32835f81b9.
22. Huang Z, Chen X, Yu B, He J, Chen D. MicroRNA-27a promotes myoblast proliferation by targeting myostatin. Biochem Biophys Res Commun 2012, 423:265-269. doi: 10.1016/j.bbrc.2012.05.106.
23. Karakikes I, Chaanine AH, Kang S, Mukete BN, Jeong D, Zhang S, Hajjar RJ, Lebeche D. Therapeutic cardiac-targeted delivery of miR-1 reverses pressure overload-induced cardiac hypertrophy and attenuates pathological remodeling. J Am Heart Assoc 2013, 2:e000078. doi: 10.1161/JAHA.113.000078.
24. Miyazaki Y, Adachi H, Katsuno M, Minamiyama M, Jiang Y-M, Huang Z, Doi H, Matsumoto S, Kondo N, Iida M, et al. Viral delivery of miR-196a ameliorates the SBMA phenotype via the silencing of CELF2. Nat Med 2012, 18:1136-1141. doi: 10.1038/nm.2791.
25. Wang XH, Hu Z, Klein JD, Zhang L, Fang F, Mitch WE. Decreased miR-29 suppresses myogenesis in CKD. J Am Soc Nephrol 2011, 22:2068-2076. doi: 10.1681/ASN.2010121278.
26. Liang Y, Ridzon D, Wong L, Chen C. Characterization of microRNA expression profiles in normal human tissues. BMC Genomics 2007, 8:166. doi: 10.1186/1471-2164-8-166.
27. Lu L, Zhou L, Chen EZ, Sun K, Jiang P, Wang L, Su X, Sun H, Wang H. A novel YY1-miR-1 regulatory circuit in skeletal myogenesis revealed by genome-wide prediction of YY1-miRNA network. PLoS One 2012, 7:e27596. doi: 10.1371/journal.pone.0027596.
28. Koning M, Werker PMN, van der Schaft DWJ, Bank RA, Harmsen MC. MicroRNA-1 and microRNA-206 improve differentiation potential of human satellite cells: a novel approach for tissue engineering of skeletal muscle. Tissue Eng A 2012, 18:889-898. doi: 10.1089/ten.TEA.2011.0191.
29. Boutz PL, Chawla G, Stoilov P, Black DL. MicroRNAs regulate the expression of the alternative splicing factor nPTB during muscle development. Genes Dev 2007, 21:71-84. doi: 10.1101/gad.1500707.
30. Chen X, Wang K, Chen J, Guo J, Yin Y, Cai X, Guo X, Wang G, Yang R, Zhu L, et al. In vitro evidence suggests that miR-133a-mediated regulation of uncoupling protein 2 (UCP2) is an indispensable step in myogenic differentiation. J Biol Chem 2008, 284:5362-5369. doi: 10.1074/jbc.M807523200.
31. Anderson C, Catoe H, Werner R. MIR-206 regulates connexin43 expression during skeletal muscle development. Nucleic Acids Res 2006, 34:5863-5871. doi: 10.1093/nar/gkl743.
32. Taulli R, Bersani F, Foglizzo V, Linari A, Vigna E, Ladanyi M, Tuschl T, Ponzetto C. The muscle-specific microRNA miR-206 blocks human rhabdomyosarcoma growth in xenotransplanted mice by promoting myogenic differentiation. J Clin Invest 2009, 119:2366-2378. doi: 10.1172/JCI38075.
33. Yan D, Dong XDE, Chen X, Wang L, Lu C, Wang J, Qu J, Tu L. MicroRNA-1/206 targets c-Met and inhibits rhabdomyosarcoma development. J Biol Chem 2009, 284:29596-29604. doi: 10.1074/jbc.M109.020511.
34. Cheung TH, Quach NL, Charville GW, Liu L, Park L, Edalati A, Yoo B, Hoang P, Rando TA. Maintenance of muscle stem-cell quiescence by microRNA-489. Nature 2012, 482:524-528. doi: 10.1038/nature10834.
35. Sun Q, Zhang Y, Yang G, Chen X, Zhang Y, Cao G, Wang J, Sun Y, Zhang P, Fan M, et al. Transforming growth factor-β-regulated miR-24 promotes skeletal muscle differentiation. Nucleic Acids Res 2008, 36:2690-2699. doi: 10.1093/nar/gkn032.
36. Wong CF, Tellam RL. MicroRNA-26a targets the histone methyltransferase enhancer of Zeste homolog 2 during myogenesis. J Biol Chem 2008, 283:9836-9843. doi: 10.1074/jbc.M709614200.
37. Wang H, Garzon R, Sun H, Ladner KJ, Singh R, Dahlman J, Cheng A, Hall BM, Qualman SJ, Chandler DS, et al. NF-κB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381. doi: 10.1016/j.ccr.2008.10.006.
38. Winbanks CE, Wang B, Beyer C, Koh P, White L, Kantharidis P, Gregorevic P. TGF-β regulates miR-206 and miR-29 to control myogenic differentiation through regulation of HDAC4. J Biol Chem 2011, 286:13805-13814. doi: 10.1074/jbc.M110.192625.
39. Ge Y, Sun Y, Chen J. IGF-II is regulated by microRNA-125b in skeletal myogenesis. J Cell Biol 2011, 192:69-81. doi: 10.1083/jcb.201007165.
40. Naguibneva I, Ameyar-Zazoua M, Polesskaya A, Ait-Si-Ali S, Groisman R, Souidi M, Cuvellier S, Harel-Bellan A. The microRNA miR-181 targets the homeobox protein Hox-A11 during mammalian myoblast differentiation. Nat Cell Biol 2006, 8:278-284. doi: 10.1038/ncb1373.
41. Juan AH, Kumar RM, Marx JG, Young RA, Sartorelli V. Mir-214-dependent regulation of the polycomb protein Ezh2 in skeletal muscle and embryonic stem cells. Mol Cell 2009, 36:61-74. doi: 10.1016/j.molcel.2009.08.008.
42. Liu J, Luo X-J, Xiong A-W, Zhang Z, Yue S, Zhu M-S, Cheng SY. MicroRNA-214 promotes myogenic differentiation by facilitating exit from mitosis via down-regulation of proto-oncogene N-ras. J Biol Chem 2010, 285:26599-26607. doi: 10.1074/jbc.M110.115824.
43. Cardinali B, Castellani L, Fasanaro P, Basso A, Alemà S, Martelli F, Falcone G. MicroRNA-221 and microRNA-222 modulate differentiation and maturation of skeletal muscle cells. PLoS One 2009, 4:e7607. doi: 10.1371/journal.pone.0007607.
44. Sarkar S, Dey BK, Dutta A. MiR-322/424 and -503 are induced during muscle differentiation and promote cell cycle quiescence and differentiation by down-regulation of Cdc25A. Mol Biol Cell 2010, 21:2138-2149. doi: 10.1091/mbc.E10-01-0062.
45. Chen Y, Gelfond J, McManus LM, Shireman PK. Temporal microRNA expression during in vitro myogenic progenitor cell proliferation and differentiation: regulation of proliferation by miR-682. Physiol Genomics 2011, 43:621-630. doi: 10.1152/physiolgenomics.00136.2010.
46. Dmitriev P, Barat A, Polesskaya A, O'Connell MJ, Robert T, Dessen P, Walsh TA, Lazar V, Turki A, Carnac G, et al. Simultaneous miRNA and mRNA transcriptome profiling of human myoblasts reveals a novel set of myogenic differentiation-associated miRNAs and their target genes. BMC Genomics 2013, 14:265. doi: 10.1186/1471-2164-14-265.
47. Liu H, Chen S-E, Jin B, Carson JA, Niu A, Durham W, Lai J-Y, Li Y-P. TIMP3: a physiological regulator of adult myogenesis. J Cell Sci 2010, 123:2914-2921. doi: 10.1242/jcs.057620.
48. McCarthy JJ, Esser KA, Peterson CA, Dupont-Versteegden EE. Evidence of MyomiR network regulation of β-myosin heavy chain gene expression during skeletal muscle atrophy. Physiol Genomics 2009, 39:219-226. doi: 10.1152/physiolgenomics.00042.2009.
49. Wang L, Chen X, Zheng Y, Li F, Lu Z, Chen C, Liu J, Wang Y, Peng Y, Shen Z, et al. MiR-23a inhibits myogenic differentiation through down regulation of fast myosin heavy chain isoforms. Exp Cell Res 2012, 318:2324-2334. doi: 10.1016/j.yexcr.2012.06.018.
50. Gan Z, Rumsey J, Hazen BC, Lai L, Leone TC, Vega RB, Xie H, Conley KE, Auwerx J, Smith SR, et al. Nuclear receptor/microRNA circuitry links muscle fiber type to energy metabolism. J Clin Invest 2013, 123:2564-2575. doi: 10.1172/JCI67652.
51. Safdar A, Abadi A, Akhtar M, Hettinga BP, Tarnopolsky MA. miRNA in the regulation of skeletal muscle adaptation to acute endurance exercise in C57Bl/6J male mice. PLoS One 2009, 4:e5610. doi: 10.1371/journal.pone.0005610.
52. Nielsen S, Scheele C, Yfanti C, Åkerström T, Nielsen AR, Pedersen BK, Laye M. Muscle specific microRNAs are regulated by endurance exercise in human skeletal muscle. J Physiol 2010, 588:4029-4037. doi: 10.1113/jphysiol.2010.189860.
53. Lewis A, Riddoch-Contreras J, Natanek SA, Donaldson A, Man WD-C, Moxham J, Hopkinson NS, Polkey MI, Kemp PR. Downregulation of the serum response factor/miR-1 axis in the quadriceps of patients with COPD. Thorax 2011, 67:26-34. doi: 10.1136/thoraxjnl-2011-200309.
54. Aoi W, Ichikawa H, Mune K, Tanimura Y, Mizushima K, Naito Y, Yoshikawa T. Muscle-enriched microRNA miR-486 decreases in circulation in response to exercise in young men. Front Physiol 2013, 4:80. doi: 10.3389/fphys.2013.00080.
55. Aoi W, Naito Y, Mizushima K, Takanami Y, Kawai Y, Ichikawa H, Yoshikawa T. The microRNA miR-696 regulates PGC-1{α} in mouse skeletal muscle in response to physical activity. Am J Physiol Endocrinol Metab 2010, 298:E799-E806. doi: 10.1152/ajpendo.00448.2009.
56. Drummond MJ, McCarthy JJ, Sinha M, Spratt HM, Volpi E, Esser KA, Rasmussen BB. Aging and microRNA expression in human skeletal muscle: a microarray and bioinformatics analysis. Physiol Genomics 2010, 43:595-603. doi: 10.1152/physiolgenomics.00148.2010.
57. Režen T, Kovanda A, Mekjavić IB, Eiken O, Rogelj B. Expression changes in human skeletal muscle miRNAs following 10 days of bed rest in young healthy males. Acta Physiol (Oxf) 2014, 210:655-666. doi: 10.1111/apha.12228.
58. Ringholm S, Biensø RS, Kiilerich K, Guadalupe-Grau A, Aachmann-Andersen NJ, Saltin B, Plomgaard P, Lundby C, Wojtaszewski JFP, Calbet JA, et al. Bed rest reduces metabolic protein content and abolishes exercise-induced mRNA responses in human skeletal muscle. Am J Physiol Endocrinol Metab 2011, 301:E649-E658. doi: 10.1152/ajpendo.00230.2011.
59. Eisenberg I, Eran A, Nishino I, Moggio M, Lamperti C, Amato AA, Lidov HG, Kang PB, North KN, Mitrani-Rosenbaum S, et al. Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A 2007, 104:17016-17021. doi: 10.1073/pnas.0708115104.
60. Greco S, De Simone M, Colussi C, Zaccagnini G, Fasanaro P, Pescatori M, Cardani R, Perbellini R, Isaia E, Sale P, et al. Common micro-RNA signature in skeletal muscle damage and regeneration induced by Duchenne muscular dystrophy and acute ischemia. FASEB J 2009, 23:3335-3346. doi: 10.1096/fj.08-128579.
61. Maciotta S, Meregalli M, Cassinelli L, Parolini D, Farini A, Fraro GD, Gandolfi F, Forcato M, Ferrari S, Gabellini D, et al. Hmgb3 is regulated by microRNA-206 during muscle regeneration. PLoS One 2012, 7:e43464. doi: 10.1371/journal.pone.0043464.
62. Wada S, Kato Y, Okutsu M, Miyaki S, Suzuki K, Yan Z, Schiaffino S, Asahara H, Ushida T, Akimoto T. Translational suppression of atrophic regulators by microRNA-23a integrates resistance to skeletal muscle atrophy. J Biol Chem 2011, 286:38456-38465. doi: 10.1074/jbc.M111.271270.
63. Jeng S-F, Rau C-S, Liliang P-C, Wu C-J, Lu T-H, Chen Y-C, Lin C-J, Hsieh C-H. Profiling muscle-specific microRNA expression after peripheral denervation and reinnervation in a rat model. J Neurotrauma 2009, 26:2345-2353. doi: 10.1089/neu.2009.0960.
64. Williams AH, Valdez G, Moresi V, Qi X, McAnally J, Elliott JL, Bassel-Duby R, Sanes JR, Olson EN. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326:1549-1554. doi: 10.1126/science.1181046.
65. Buckingham M. Skeletal muscle formation in vertebrates. Curr Opin Genet Dev 2001, 11:440-448.
66. Parker MH, Seale P, Rudnicki MA. Looking back to the embryo: defining transcriptional networks in adult myogenesis. Nat Rev Genet 2003, 4:497-507. doi: 10.1038/nrg1109.
67. Naya F, Olson E. MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol 1999, 11:683-688. doi: 10.1016/S0955-0674(99)00036-8.
68. Perdiguero E, Sousa-Victor P, Ballestar E, Muñoz-Cánoves P. Epigenetic regulation of myogenesis. Epigenetics 2009, 4:541-550. doi: 10.4161/epi.4.8.10258.
69. Saccone V, Puri PL. Epigenetic regulation of skeletal myogenesis. Organogenesis 2010, 6:48-53. doi: 10.4161/org.6.1.11293.
70. Rao PK, Toyama Y, Chiang HR, Gupta S, Bauer M, Medvid R, Reinhardt F, Liao R, Krieger M, Jaenisch R, et al. Loss of cardiac microRNA-mediated regulation leads to dilated cardiomyopathy and heart failure. Circ Res 2009, 105:585-594. doi: 10.1161/CIRCRESAHA.109.200451.
71. O'Rourke JR, Georges SA, Seay HR, Tapscott SJ, McManus MT, Goldhamer DJ, Swanson MS, Harfe BD. Essential role for Dicer during skeletal muscle development. Dev Biol 2007, 311:359-368. doi: 10.1016/j.ydbio.2007.08.032.
72. Chen J-F, Mandel EM, Thomson JM, Wu Q, Callis TE, Hammond SM, Conlon FL, Wang D-Z. The role of microRNA-1 and microRNA-133 in skeletal muscle proliferation and differentiation. Nat Genet 2005, 38:228-233. doi: 10.1038/ng1725.
73. Chen J-F, Tao Y, Li J, Deng Z, Yan Z, Xiao X, Wang D-Z. microRNA-1 and microRNA-206 regulate skeletal muscle satellite cell proliferation and differentiation by repressing Pax7. J Cell Biol 2010, 190:867-879. doi: 10.1083/jcb.200911036.
74. Williams AH, Liu N, van Rooij E, Olson EN. MicroRNA control of muscle development and disease. Curr Opin Cell Biol 2009, 21:461-469. doi: 10.1016/j.ceb.2009.01.029.
75. Liu N, Williams AH, Kim Y, McAnally J, Bezprozvannaya S, Sutherland LB, Richardson JA, Bassel-Duby R, Olson EN. An intragenic MEF2-dependent enhancer directs muscle-specific expression of microRNAs 1 and 133. Proc Natl Acad Sci U S A 2007, 104:20844-20849. doi: 10.1073/pnas.0710558105.
76. Rao PK, Kumar RM, Farkhondeh M, Baskerville S, Lodish HF. Myogenic factors that regulate expression of muscle-specific microRNAs. Proc Natl Acad Sci U S A 2006, 103:8721-8726. doi: 10.1073/pnas.0602831103.
77. Rosenberg MI, Georges SA, Asawachaicharn A, Analau E, Tapscott SJ. MyoD inhibits Fstl1 and Utrn expression by inducing transcription of miR-206. J Cell Biol 2006, 175:77-85. doi: 10.1083/jcb.200603039.
78. Sun Y, Ge Y, Drnevich J, Zhao Y, Band M, Chen J. Mammalian target of rapamycin regulates miRNA-1 and follistatin in skeletal myogenesis. J Cell Biol 2010, 189:1157-1169. doi: 10.1083/jcb.200912093.
79. Zhao Y, Samal E, Srivastava D. Serum response factor regulates a muscle-specific microRNA that targets Hand2 during cardiogenesis. Nature 2005, 436:214-220. doi: 10.1038/nature03817.
80. Kim HK. Muscle-specific microRNA miR-206 promotes muscle differentiation. J Cell Biol 2006, 174:677-687. doi: 10.1083/jcb.200603008.
81. Yin H, Pasut A, Soleimani VD, Bentzinger CF, Antoun G, Thorn S, Seale P, Fernando P, van IJcken W, Grosveld F, et al. MicroRNA-133 controls brown adipose determination in skeletal muscle satellite cells by targeting Prdm16. Cell Metab 2013, 17:210-224. doi: 10.1016/j.cmet.2013.01.004.
82. Trajkovski M, Ahmed K, Esau CC, Stoffel M. MyomiR-133 regulates brown fat differentiation through Prdm16. Nat Cell Biol 2012, 14:1330-1335. doi: 10.1038/ncb2612.
83. Yeung F, Chung E, Guess MG, Bell ML, Leinwand LA. Myh7b/miR-499 gene expression is transcriptionally regulated by MRFs and Eos. Nucleic Acids Res 2012, 40:7303-7318. doi: 10.1093/nar/gks466.
84. Oliveira-Carvalho V, Carvalho VO, Bocchi EA. The emerging role of miR-208a in the heart. DNA Cell Biol 2013, 32:8-12. doi: 10.1089/dna.2012.1787.
85. Dey BK, Gagan J, Dutta A. miR-206 and -486 induce myoblast differentiation by downregulating Pax7. Mol Cell Biol 2011, 31:203-214. doi: 10.1128/MCB.01009-10.
86. Crist CG, Montarras D, Pallafacchina G, Rocancourt D, Cumano A, Conway SJ, Buckingham M. Muscle stem cell behavior is modified by microRNA-27 regulation of Pax3 expression. Proc Natl Acad Sci U S A 2009, 106:13383-13387. doi: 10.1073/pnas.0900210106.
87. Nakasa T, Ishikawa M, Shi M, Shibuya H, Adachi N, Ochi M. Acceleration of muscle regeneration by local injection of muscle-specific microRNAs in rat skeletal muscle injury model. J Cell Mol Med 2010, 14:2495-2505. doi: 10.1111/j.1582-4934.2009.00898.x.
88. Scott W, Stevens J, Binder-Macleod SA. Human skeletal muscle fiber type classifications. Phys Ther 2001, 81:1810-1816.
89. 2 uptake kinetics and shift in muscle fiber type in high-altitude trekkers. J Appl Physiol (1985) 2011, 111:1597-1605. doi: 10.1152/japplphysiol.01439.2010.
90. Pette D, Staron RS. Mammalian skeletal muscle fiber type transitions. Int Rev Cytol 1997, 170:143-223.
91. Drummond MJ, McCarthy JJ, Fry CS, Esser KA, Rasmussen BB. Aging differentially affects human skeletal muscle microRNA expression at rest and after an anabolic stimulus of resistance exercise and essential amino acids. Am J Physiol Endocrinol Metab 2008, 295:E1333-E1340. doi: 10.1152/ajpendo.90562.2008.
92. Drummond MJ, Glynn EL, Fry CS, Dhanani S, Volpi E, Rasmussen BB. Essential amino acids increase microRNA-499, -208b, and -23a and downregulate myostatin and myocyte enhancer factor 2C mRNA expression in human skeletal muscle. J Nutr 2009, 139:2279-2284. doi: 10.3945/jn.109.112797.
93. Yuasa K, Hagiwara Y, Ando M, Nakamura A, Takeda S, Hijikata T. MicroRNA-206 is highly expressed in newly formed muscle fibers: implications regarding potential for muscle regeneration and maturation in muscular dystrophy. Cell Struct Funct 2008, 33:163-169.
94. McCarthy JJ. The MyomiR network in skeletal muscle plasticity. Exerc Sport Sci Rev 2011, 39:150-154. doi: 10.1097/JES.0b013e31821c01e1.
95. Rubio MD, Johnson R, Miller CA, Huganir RL, Rumbaugh G. Regulation of synapse structure and function by distinct myosin II motors. J Neurosci 2011, 31:1448-1460. doi: 10.1523/JNEUROSCI.3294-10.2011.
96. Small EM, O'Rourke JR, Moresi V, Sutherland LB, McAnally J, Gerard RD, Richardson JA, Olson EN. Regulation of PI3-kinase/Akt signaling by muscle-enriched microRNA-486. Proc Natl Acad Sci U S A 2010, 107:4218-4223. doi: 10.1073/pnas.1000300107.
97. Wilfred BR, Wang W-X, Nelson PT. Energizing miRNA research: a review of the role of miRNAs in lipid metabolism, with a prediction that miR-103/107 regulates human metabolic pathways. Mol Genet Metab 2007, 91:209-217. doi: 10.1016/j.ymgme.2007.03.011.
98. Lin J, Wu H, Tarr PT, Zhang C-Y, Wu Z, Boss O, Michael LF, Puigserver P, Isotani E, Olson EN, et al. Transcriptional co-activator PGC-1 α drives the formation of slow-twitch muscle fibres. Nature 2002, 418:797-801. doi: 10.1038/nature00904.
99. Martin B, Ji S, Maudsley S, Mattson MP. "Control" laboratory rodents are metabolically morbid: why it matters. Proc Natl Acad Sci U S A 2010, 107:6127-6133. doi: 10.1073/pnas.0912955107.
100. Leung AKL, Sharp PA. MicroRNA functions in stress responses. Mol Cell 2010, 40:205-215. doi: 10.1016/j.molcel.2010.09.027.
101. Scott S, Kranz JE, Cole J, Lincecum JM, Thompson K, Kelly N, Bostrom A, Theodoss J, Al-Nakhala BM, Vieira FG, et al. Design, power, and interpretation of studies in the standard murine model of ALS. Amyotroph Lateral Scler 2008, 9:4-15. doi: 10.1080/17482960701856300.
102. Partridge TA. The mdx mouse model as a surrogate for Duchenne muscular dystrophy. FEBS J 2013, 280:4177-4186. doi: 10.1111/febs.12267.
103. Deng Z, Chen J-F, Wang D-Z. Transgenic overexpression of miR-133a in skeletal muscle. BMC Musculoskelet Disord 2011, 12:115. doi: 10.1186/1471-2474-12-115.
104. Alibegovic AC, Højbjerre L, Sonne MP, van Hall G, Alsted TJ, Kiens B, Stallknecht B, Dela F, Vaag A. Increased rate of whole body lipolysis before and after 9 days of bed rest in healthy young men born with low birth weight. Am J Physiol Endocrinol Metab 2010, 298:E555-E564. doi: 10.1152/ajpendo.00223.2009.
105. Alibegovic AC, Sonne MP, Højbjerre L, Bork-Jensen J, Jacobsen S, Nilsson E, Faerch K, Hiscock N, Mortensen B, Friedrichsen M, et al. Insulin resistance induced by physical inactivity is associated with multiple transcriptional changes in skeletal muscle in young men. Am J Physiol Endocrinol Metab 2010, 299:E752-E763. doi: 10.1152/ajpendo.00590.2009.
106. Bergouignan A, Rudwill F, Simon C, Blanc S. Physical inactivity as the culprit of metabolic inflexibility: evidence from bed-rest studies. J Appl Physiol (1985) 2011, 111:1201-1210. doi: 10.1152/japplphysiol.00698.2011.
107. Brocca L, Cannavino J, Coletto L, Biolo G, Sandri M, Bottinelli R, Pellegrino MA. The time course of the adaptations of human muscle proteome to bed rest and the underlying mechanisms. J Physiol 2012, 590:5211-5230. doi: 10.1113/jphysiol.2012.240267.
108. Chopard A, Hillock S, Jasmin BJ. Molecular events and signalling pathways involved in skeletal muscle disuse-induced atrophy and the impact of countermeasures. J Cell Mol Med 2009, 13:3032-3050. doi: 10.1111/j.1582-4934.2009.00864.x.
109. Chopard A, Lecunff M, Danger R, Lamirault G, Bihouee A, Teusan R, Jasmin BJ, Marini JF, Leger JJ. Large-scale mRNA analysis of female skeletal muscles during 60 days of bed rest with and without exercise or dietary protein supplementation as countermeasures. Physiol Genomics 2009, 38:291-302. doi: 10.1152/physiolgenomics.00036.2009.
110. Marimuthu K, Murton AJ, Greenhaff PL. Mechanisms regulating muscle mass during disuse atrophy and rehabilitation in humans. J Appl Physiol (1985) 2011, 110:555-560. doi: 10.1152/japplphysiol.00962.2010.
111. Moriggi M, Vasso M, Fania C, Capitanio D, Bonifacio G, Salanova M, Blottner D, Rittweger J, Felsenberg D, Cerretelli P, et al. Long term bed rest with and without vibration exercise countermeasures: effects on human muscle protein dysregulation. Proteomics 2010, 10:3756-3774. doi: 10.1002/pmic.200900817.
112. Allen DL, Bandstra ER, Harrison BC, Thorng S, Stodieck LS, Kostenuik PJ, Morony S, Lacey DL, Hammond TG, Leinwand LL, et al. Effects of spaceflight on murine skeletal muscle gene expression. J Appl Physiol (1985) 2009, 106:582-595. doi: 10.1152/japplphysiol.90780.2008.
113. Chugh P, Dittmer DP. Potential pitfalls in microRNA profiling. Wiley Interdiscip Rev RNA 2012, 3:601-616. doi: 10.1002/wrna.1120.
114. Granjon A, Gustin M-P, Rieusset J, Lefai E, Meugnier E, Guller I, Cerutti C, Paultre C, Disse E, Rabasa-Lhoret R, et al. The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway. Diabetes 2009, 58:2555-2564. doi: 10.2337/db09-0165.
115. Alexander MS, Casar J, Motohashi N, Myers JA, Eisenberg I, Gonzalez RT, Estrella EA, Kang PB, Kawahara G, Kunkel LM. Regulation of DMD pathology by an ankyrin-encoded miRNA. Skelet Muscle 2011, 1:27. doi: 10.1186/2044-5040-1-27.
116. Cacchiarelli D, Incitti T, Martone J, Cesana M, Cazzella V, Santini T, Sthandier O, Bozzoni I. miR-31 modulates dystrophin expression: new implications for Duchenne muscular dystrophy therapy. EMBO Rep 2011, 12:136-141. doi: 10.1038/embor.2010.208.
117. Cacchiarelli D, Legnini I, Martone J, Cazzella V, D'Amico A, Bertini E, Bozzoni I. miRNAs as serum biomarkers for Duchenne muscular dystrophy. EMBO Mol Med 2011, 3:258-265. doi: 10.1002/emmm.201100133.
118. Alexander MS, Kawahara G, Motohashi N, Casar JC, Eisenberg I, Myers JA, Gasperini MJ, Estrella EA, Kho AT, Mitsuhashi S, et al. MicroRNA-199a is induced in dystrophic muscle and affects WNT signaling, cell proliferation, and myogenic differentiation. Cell Death Differ 2013, 20:1194-1208. doi: 10.1038/cdd.2013.62.
119. Liu N, Williams AH, Maxeiner JM, Bezprozvannaya S, Shelton JM, Richardson JA, Bassel-Duby R, Olson EN. microRNA-206 promotes skeletal muscle regeneration and delays progression of Duchenne muscular dystrophy in mice. J Clin Invest 2012, 122:2054-2065. doi: 10.1172/JCI62656.
120. Wang L, Zhou L, Jiang P, Lu L, Chen X, Lan H, Guttridge DC, Sun H, Wang H. Loss of miR-29 in myoblasts contributes to dystrophic muscle pathogenesis. Mol Ther 2012, 20:1222-1233. doi: 10.1038/mt.2012.35.
121. Russell AP, Wada S, Vergani L, Hock MB, Lamon S, Léger B, Ushida T, Cartoni R, Wadley GD, Hespel P, et al. Disruption of skeletal muscle mitochondrial network genes and miRNAs in amyotrophic lateral sclerosis. Neurobiol Dis 2012, 49C:107-117. doi: 10.1016/j.nbd.2012.08.015.
122. Haramati S, Chapnik E, Sztainberg Y, Eilam R, Zwang R, Gershoni N, McGlinn E, Heiser PW, Wills A-M, Wirguin I, et al. miRNA malfunction causes spinal motor neuron disease. Proc Natl Acad Sci U S A 2010, 107:13111-13116. doi: 10.1073/pnas.1006151107.
123. Gambardella S, Rinaldi F, Lepore SM, Viola A, Loro E, Angelini C, Vergani L, Novelli G, Botta A. Overexpression of microRNA-206 in the skeletal muscle from myotonic dystrophy type 1 patients. J Transl Med 2010, 8:48. doi: 10.1186/1479-5876-8-48.
124. Xu J, Li R, Workeneh B, Dong Y, Wang X, Hu Z. Transcription factor FoxO1, the dominant mediator of muscle wasting in chronic kidney disease, is inhibited by microRNA-486. Kidney Int 2012, 82:401-411. doi: 10.1038/ki.2012.84.
125. Hoffman EP, Fischbeck KH, Brown RH, Johnson M, Medori R, Loike JD, Harris JB, Waterston R, Brooke M, Specht L. Characterization of dystrophin in muscle-biopsy specimens from patients with Duchenne's or Becker's muscular dystrophy. N Engl J Med 1988, 318:1363-1368. doi: 10.1056/NEJM198805263182104.
126. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, Chou TT, Bruce J, Schuck T, Grossman M, Clark CM, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133. doi: 10.1126/science.1134108.
127. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, Rogelj B, Ackerley S, Durnall JC, Williams KL, Buratti E, et al. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672. doi: 10.1126/science.1154584.
128. Vance C, Rogelj B, Hortobagyi T, De Vos KJ, Nishimura AL, Sreedharan J, Hu X, Smith B, Ruddy D, Wright P, et al. Mutations in FUS, an RNA processing protein, cause familial amyotrophic lateral sclerosis type 6. Science 2009, 323:1208-1211. doi: 10.1126/science.1165942.
129. Vance C, Scotter EL, Nishimura AL, Troakes C, Mitchell JC, Kathe C, Urwin H, Manser C, Miller CC, Hortobágyi T, et al. ALS mutant FUS disrupts nuclear localization and sequesters wild-type FUS within cytoplasmic stress granules. Hum Mol Genet 2013, 22:2676-2688. doi: 10.1093/hmg/ddt117.
130. Tollervey JR, Curk T, Rogelj B, Briese M, Cereda M, Kayikci M, König J, Hortobágyi T, Nishimura AL, Župunski V, et al. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat Neurosci 2011, 14:452-458. doi: 10.1038/nn.2778.
131. Rogelj B, Easton LE, Bogu GK, Stanton LW, Rot G, Curk T, Zupan B, Sugimoto Y, Modic M, Haberman N, et al. Widespread binding of FUS along nascent RNA regulates alternative splicing in the brain. Sci Rep 2012, 2:603. doi: 10.1038/srep00603.
132. Nishimura AL, Zupunski V, Troakes C, Kathe C, Fratta P, Howell M, Gallo J-M, Hortobágyi T, Shaw CE, Rogelj B. Nuclear import impairment causes cytoplasmic trans-activation response DNA-binding protein accumulation and is associated with frontotemporal lobar degeneration. Brain 2010, 133:1763-1771. doi: 10.1093/brain/awq111.
133. Gregory RI, Yan K-P, Amuthan G, Chendrimada T, Doratotaj B, Cooch N, Shiekhattar R. The microprocessor complex mediates the genesis of microRNAs. Nature 2004, 432:235-240. doi: 10.1038/nature03120.
134. Kawahara Y, Mieda-Sato A. TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U S A 2012, 109:3347-3352. doi: 10.1073/pnas.1112427109.
135. Morlando M, Dini Modigliani S, Torrelli G, Rosa A, Di Carlo V, Caffarelli E, Bozzoni I. FUS stimulates microRNA biogenesis by facilitating co-transcriptional Drosha recruitment: FUS participates in microRNA biogenesis. EMBO J 2012, 31:4502-4510. doi: 10.1038/emboj.2012.319.
136. Koval ED, Shaner C, Zhang P, du Maine X, Fischer K, Tay J, Chau BN, Wu GF, Miller TM. Method for widespread microRNA-155 inhibition prolongs survival in ALS-model mice. Hum Mol Genet 2013, 22:4127-4135. doi: 10.1093/hmg/ddt261.
137. Schmidt J, Barthel K, Zschüntzsch J, Muth IE, Swindle EJ, Hombach A, Sehmisch S, Wrede A, Lühder F, Gold R, et al. Nitric oxide stress in sporadic inclusion body myositis muscle fibres: inhibition of inducible nitric oxide synthase prevents interleukin-1β-induced accumulation of β-amyloid and cell death. Brain 2012, 135:1102-1114. doi: 10.1093/brain/aws046.
138. Morosetti R, Gliubizzi C, Sancricca C, Broccolini A, Gidaro T, Lucchini M, Mirabella M. TWEAK in inclusion-body myositis muscle: possible pathogenic role of a cytokine inhibiting myogenesis. Am J Pathol 2012, 180:1603-1613. doi: 10.1016/j.ajpath.2011.12.027.
139. Cacchiarelli D, Martone J, Girardi E, Cesana M, Incitti T, Morlando M, Nicoletti C, Santini T, Sthandier O, Barberi L, et al. MicroRNAs involved in molecular circuitries relevant for the Duchenne muscular dystrophy pathogenesis are controlled by the dystrophin/nNOS pathway. Cell Metab 2010, 12:341-351. doi: 10.1016/j.cmet.2010.07.008.
140. Panguluri SK, Bhatnagar S, Kumar A, McCarthy JJ, Srivastava AK, Cooper NG, Lundy RF, Kumar A. Genomic profiling of messenger RNAs and microRNAs reveals potential mechanisms of TWEAK-induced skeletal muscle wasting in mice. PLoS One 2010, 5:e8760. doi: 10.1371/journal.pone.0008760.
141. Stappert L, Borghese L, Roese-Koerner B, Weinhold S, Koch P, Terstegge S, Uhrberg M, Wernet P, Brüstle O. MicroRNA-based promotion of human neuronal differentiation and subtype specification. PLoS One 2013, 8:e59011. doi: 10.1371/journal.pone.0059011.
142. Rathore MG, Saumet A, Rossi J-F, de Bettignies C, Tempé D, Lecellier C-H, Villalba M. The NF-κB member p65 controls glutamine metabolism through miR-23a. Int J Biochem Cell Biol 2012, 44:1448-1456. doi: 10.1016/j.biocel.2012.05.011.
143. Wang XH, Du J, Klein JD, Bailey JL, Mitch WE. Exercise ameliorates chronic kidney disease-induced defects in muscle protein metabolism and progenitor cell function. Kidney Int 2009, 76:751-759. doi: 10.1038/ki.2009.260.
144. Zhang L, Rajan V, Lin E, Hu Z, Han HQ, Zhou X, Song Y, Min H, Wang X, Du J, et al. Pharmacological inhibition of myostatin suppresses systemic inflammation and muscle atrophy in mice with chronic kidney disease. FASEB J 2011, 25:1653-1663. doi: 10.1096/fj.10-176917.
145. Kornfeld SF, Biggar KK, Storey KB. Differential expression of mature microRNAs involved in muscle maintenance of hibernating little brown bats, Myotis lucifugus: a model of muscle atrophy resistance. Genomics Proteomics Bioinformatics 2012, 10:295-301. doi: 10.1016/j.gpb.2012.09.001.
146. Maistrovski Y, Biggar KK, Storey KB. HIF-1α regulation in mammalian hibernators: role of non-coding RNA in HIF-1α control during torpor in ground squirrels and bats. J Comp Physiol B 2012, 182:849-859. doi: 10.1007/s00360-012-0662-y.
147. Clop A, Marcq F, Takeda H, Pirottin D, Tordoir X, Bibé B, Bouix J, Caiment F, Elsen J-M, Eychenne F, et al. A mutation creating a potential illegitimate microRNA target site in the myostatin gene affects muscularity in sheep. Nat Genet 2006, 38:813-818. doi: 10.1038/ng1810.